HCP
PFE icon

Hexagon Capital Partners’s Pfizer PFE Stock Holding History

Hexagon Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
54,852
+234
+0.4% +$6.12K 0.19% 58
2026
Q1 		$1.53M Sell
54,618
-4,321
-7% -$115K 0.22% 42
2025
Q4 		$1.47M Buy
58,939
+3,261
+6% +$82.2K 0.27% 34
2025
Q3 		$1.42M Sell
55,678
-768
-1% -$19K 0.28% 33
2025
Q2 		$1.37M Buy
56,446
+716
+1% +$16.7K 0.3% 27
2025
Q1 		$1.41M Buy
55,730
+2,307
+4% +$60.4K 0.27% 35
2024
Q4 		$1.42M Buy
53,423
+889
+2% +$24.1K 0.26% 32
2024
Q3 		$1.52M Buy
52,534
+1,911
+4% +$55.7K 0.3% 24
2024
Q2 		$1.42M Buy
50,623
+11,088
+28% +$305K 0.31% 25
2024
Q1 		$1.1M Sell
39,535
-1,627
-4% -$45.1K 0.24% 35
2023
Q4 		$1.19M Buy
41,162
+3,101
+8% +$93.7K 0.29% 27
2023
Q3 		$1.26M Buy
38,061
+387
+1% +$13.7K 0.33% 23
2023
Q2 		$1.38M Buy
37,674
+2,814
+8% +$110K 0.36% 22
2023
Q1 		$1.42M Buy
34,860
+4,753
+16% +$205K 0.4% 21
2022
Q4 		$1.54M Sell
30,107
-3,306
-10% -$159K 0.45% 13
2022
Q3 		$1.46M Buy
33,413
+11,009
+49% +$535K 0.43% 17
2022
Q2 		$1.18M Buy
22,404
+1,745
+8% +$88.9K 0.35% 32
2022
Q1 		$1.07M Sell
20,659
-253
-1% -$13.1K 0.28% 41
2021
Q4 		$1.24M Buy
20,912
+1,257
+6% +$62.3K 0.32% 35
2021
Q3 		$845K Sell
19,655
-1,033
-5% -$45.8K 0.25% 47
2021
Q2 		$810K Buy
20,688
+305
+1% +$11.9K 0.22% 48
2021
Q1 		$738K Buy
20,383
+1,629
+9% +$57.8K 0.2% 45
2020
Q4 		$690K Buy
18,754
+2
+0% +$73 0.2% 46
2020
Q3 		$644K Buy
+18,752
New +$657K 0.21% 46

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hexagon Capital Partners's PFE Position: Q2 2026 in Review

Hexagon Capital Partners increased its Pfizer (PFE) stake by 0.43% in Q2 2026, buying an estimated $6.12K and bringing the position to 54,852 shares worth $1.32M. The position accounts for 0.19% of the portfolio, ranked #58.

Hexagon Capital Partners first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.54M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hexagon Capital Partners held 54,852 shares of Pfizer worth $1.32M as of Q2 2026.
  • Hexagon Capital Partners bought 234 Pfizer shares in Q2 2026, an estimated $6.12K.
  • Pfizer made up 0.19% of Hexagon Capital Partners's portfolio in Q2 2026, its #58 holding.
  • Hexagon Capital Partners first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • Hexagon Capital Partners's Pfizer position peaked at $1.54M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.